Skip to content
10-Q

Quarterly Report

Lipella Pharmaceuticals Inc. LIPO

0001753926-25-001805

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 13, 2025 4.62M sh
Shares Diluted Q3 2025 · Sep 30, 2025 4.55M sh
Shares Diluted Q3 2025 · Sep 30, 2025 3.65M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.12M sh
Shares Diluted Q3 2025 · Sep 30, 2024 994.25K sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$3.79M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$2.96M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $1.86M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $2.18M
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.49M
Stockholders Equity Q3 2025 · Jun 30, 2025 $2.74M
Stockholders Equity Q3 2025 · Mar 31, 2025 $4.08M
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.92M
Stockholders Equity Q3 2025 · Sep 30, 2024 $1.46M
Stockholders Equity Q3 2025 · Jun 30, 2024 $1.7M
Stockholders Equity Q3 2025 · Mar 31, 2024 $2.56M
Stockholders Equity Q3 2025 · Dec 31, 2023 $3.14M
Current Liabilities Q3 2025 · Sep 30, 2025 $642.4K
Current Liabilities Q3 2025 · Dec 31, 2024 $754.42K
Total Liabilities Q3 2025 · Sep 30, 2025 $862.22K
Total Liabilities Q3 2025 · Dec 31, 2024 $754.42K
Current Assets Q3 2025 · Sep 30, 2025 $2.08M
Current Assets Q3 2025 · Dec 31, 2024 $2.62M
Total Assets Q3 2025 · Sep 30, 2025 $2.35M
Total Assets Q3 2025 · Dec 31, 2024 $2.67M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.28
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.07
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.29
Eps Diluted Q3 2025 · Sep 30, 2024 −$3.60
Eps Basic Q3 2025 · Sep 30, 2025 −$0.28
Eps Basic Q3 2025 · Sep 30, 2025 −$1.07
Eps Basic Q3 2025 · Sep 30, 2024 −$1.29
Eps Basic Q3 2025 · Sep 30, 2024 −$3.60
Sga Expense Q3 2025 · Sep 30, 2025 $553.3K
Sga Expense Q3 2025 · Sep 30, 2025 $1.67M
Sga Expense Q3 2025 · Sep 30, 2024 $493.1K
Sga Expense Q3 2025 · Sep 30, 2024 $1.44M
Rd Expense Q3 2025 · Sep 30, 2025 $720.97K
Rd Expense Q3 2025 · Sep 30, 2025 $2.51M
Rd Expense Q3 2025 · Sep 30, 2024 $1.05M
Rd Expense Q3 2025 · Sep 30, 2024 $2.55M
Net Income Q3 2025 · Sep 30, 2025 −$1.25M
Net Income Q3 2025 · Sep 30, 2025 −$3.89M
Net Income Q3 2025 · Jun 30, 2025 −$1.33M
Net Income Q3 2025 · Mar 31, 2025 −$1.31M
Net Income Q3 2025 · Sep 30, 2024 −$1.44M
Net Income Q3 2025 · Sep 30, 2024 −$3.57M
Net Income Q3 2025 · Jun 30, 2024 −$938.15K
Net Income Q3 2025 · Mar 31, 2024 −$1.19M
Operating Income Q3 2025 · Sep 30, 2025 −$1.27M
Operating Income Q3 2025 · Sep 30, 2025 −$3.96M
Operating Income Q3 2025 · Sep 30, 2024 −$1.46M
Operating Income Q3 2025 · Sep 30, 2024 −$3.63M
Revenue Q3 2025 · Sep 30, 2025 $216.12K
Revenue Q3 2025 · Sep 30, 2024 $80.38K
Revenue Q3 2025 · Sep 30, 2024 $362.69K